Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects with Recurrence of Clostridium difficile Infection
The Division of Gastroenterology and Hepatology seeks adults ages 18-75 with CDI for a research study. The purpose of the study is to evaluate potential side effects and effectiveness of taking an investigational medicine (CP101) in a single dose.
Participation includes taking the study medication, at least 4 study visits and phone calls over 6 months.
All study-related insert exams, tests and study medication are provided free of charge.
$325 for completing the study